

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | chondrocyte proliferation (GO:0035988) | 6.74672471 |
| 2 | regulation of cardiac muscle cell contraction (GO:0086004) | 5.89992207 |
| 3 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.62697477 |
| 4 | synaptic vesicle exocytosis (GO:0016079) | 5.53161683 |
| 5 | synaptic vesicle maturation (GO:0016188) | 5.24074267 |
| 6 | vocalization behavior (GO:0071625) | 5.21065765 |
| 7 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.20822083 |
| 8 | endothelial cell morphogenesis (GO:0001886) | 5.18297374 |
| 9 | glutamate secretion (GO:0014047) | 4.99901716 |
| 10 | regulation of actin filament-based movement (GO:1903115) | 4.98695940 |
| 11 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.82751997 |
| 12 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.82673297 |
| 13 | locomotory exploration behavior (GO:0035641) | 4.67022242 |
| 14 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.65333158 |
| 15 | neuronal action potential propagation (GO:0019227) | 4.63613400 |
| 16 | protein localization to synapse (GO:0035418) | 4.61060974 |
| 17 | neuron cell-cell adhesion (GO:0007158) | 4.43169616 |
| 18 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.41906143 |
| 19 | neurotransmitter secretion (GO:0007269) | 4.41372823 |
| 20 | glomerular filtration (GO:0003094) | 4.30158263 |
| 21 | response to pheromone (GO:0019236) | 4.23258414 |
| 22 | regulation of synaptic vesicle transport (GO:1902803) | 4.19040478 |
| 23 | cellular potassium ion homeostasis (GO:0030007) | 4.14006489 |
| 24 | cerebellar granule cell differentiation (GO:0021707) | 4.10047915 |
| 25 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.08878537 |
| 26 | glutamate receptor signaling pathway (GO:0007215) | 4.05067022 |
| 27 | positive regulation of synapse maturation (GO:0090129) | 4.04404936 |
| 28 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.03114748 |
| 29 | potassium ion import (GO:0010107) | 3.99391137 |
| 30 | cell migration in hindbrain (GO:0021535) | 3.93856557 |
| 31 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.89799485 |
| 32 | layer formation in cerebral cortex (GO:0021819) | 3.88244896 |
| 33 | regulation of synapse structural plasticity (GO:0051823) | 3.87826378 |
| 34 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.87418871 |
| 35 | synaptic transmission, glutamatergic (GO:0035249) | 3.84390395 |
| 36 | exploration behavior (GO:0035640) | 3.81694681 |
| 37 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.77696811 |
| 38 | sodium ion export (GO:0071436) | 3.77180863 |
| 39 | renal filtration (GO:0097205) | 3.75105890 |
| 40 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.73468284 |
| 41 | neuron-neuron synaptic transmission (GO:0007270) | 3.71524562 |
| 42 | cAMP biosynthetic process (GO:0006171) | 3.68814444 |
| 43 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.66772817 |
| 44 | neuron recognition (GO:0008038) | 3.63806580 |
| 45 | neurotransmitter transport (GO:0006836) | 3.62728950 |
| 46 | activation of protein kinase A activity (GO:0034199) | 3.61864135 |
| 47 | synaptic vesicle endocytosis (GO:0048488) | 3.58993057 |
| 48 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.58902317 |
| 49 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.58285232 |
| 50 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.55638128 |
| 51 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.53480727 |
| 52 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.51755614 |
| 53 | membrane depolarization during action potential (GO:0086010) | 3.49032353 |
| 54 | proline transport (GO:0015824) | 3.47203460 |
| 55 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.46773935 |
| 56 | gamma-aminobutyric acid transport (GO:0015812) | 3.44587245 |
| 57 | negative regulation of endothelial cell migration (GO:0010596) | 3.43594050 |
| 58 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157) | 3.41224214 |
| 59 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.41195664 |
| 60 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.40863946 |
| 61 | regulation of neurotransmitter secretion (GO:0046928) | 3.37214658 |
| 62 | positive regulation of calcium ion import (GO:0090280) | 3.35813479 |
| 63 | mating behavior (GO:0007617) | 3.34386965 |
| 64 | innervation (GO:0060384) | 3.31545843 |
| 65 | positive regulation of membrane potential (GO:0045838) | 3.30854433 |
| 66 | synapse assembly (GO:0007416) | 3.30774833 |
| 67 | regulation of synapse maturation (GO:0090128) | 3.29237079 |
| 68 | regulation of postsynaptic membrane potential (GO:0060078) | 3.28944712 |
| 69 | regulation of neurotransmitter levels (GO:0001505) | 3.25683729 |
| 70 | response to dietary excess (GO:0002021) | 3.25051850 |
| 71 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.24040773 |
| 72 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.21115057 |
| 73 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.21095360 |
| 74 | transmission of nerve impulse (GO:0019226) | 3.19997301 |
| 75 | long-term memory (GO:0007616) | 3.19766923 |
| 76 | complement activation, classical pathway (GO:0006958) | 3.17035659 |
| 77 | cell differentiation in hindbrain (GO:0021533) | 3.17002183 |
| 78 | low-density lipoprotein particle clearance (GO:0034383) | 3.16964179 |
| 79 | dendrite morphogenesis (GO:0048813) | 3.16158288 |
| 80 | prepulse inhibition (GO:0060134) | 3.15190095 |
| 81 | axonal fasciculation (GO:0007413) | 3.14936832 |
| 82 | triglyceride catabolic process (GO:0019433) | 3.14905325 |
| 83 | regulation of vesicle fusion (GO:0031338) | 3.12327937 |
| 84 | membrane depolarization (GO:0051899) | 3.12135529 |
| 85 | regulation of neurotransmitter transport (GO:0051588) | 3.12048653 |
| 86 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.10110492 |
| 87 | postsynaptic membrane organization (GO:0001941) | 3.07756205 |
| 88 | membrane hyperpolarization (GO:0060081) | 3.06626179 |
| 89 | neuromuscular process controlling posture (GO:0050884) | 3.05408559 |
| 90 | dendritic spine morphogenesis (GO:0060997) | 3.03963681 |
| 91 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.01047208 |
| 92 | regulation of sequestering of triglyceride (GO:0010889) | 2.99299987 |
| 93 | cell communication by electrical coupling (GO:0010644) | 2.99158553 |
| 94 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.98969743 |
| 95 | neuromuscular process controlling balance (GO:0050885) | 2.98510900 |
| 96 | positive regulation of receptor recycling (GO:0001921) | 2.97872787 |
| 97 | negative regulation of microtubule polymerization (GO:0031115) | 2.97431216 |
| 98 | lymphangiogenesis (GO:0001946) | 2.97368677 |
| 99 | presynaptic membrane assembly (GO:0097105) | 2.97028680 |
| 100 | auditory behavior (GO:0031223) | 2.96764699 |
| 101 | regulation of excretion (GO:0044062) | 2.96446631 |
| 102 | synaptic transmission (GO:0007268) | 2.95294109 |
| 103 | long-term synaptic potentiation (GO:0060291) | 2.93191110 |
| 104 | neuron remodeling (GO:0016322) | 2.93095457 |
| 105 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.91784295 |
| 106 | regulation of synaptic plasticity (GO:0048167) | 2.90815584 |
| 107 | cGMP-mediated signaling (GO:0019934) | 2.90776847 |
| 108 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.89042556 |
| 109 | presynaptic membrane organization (GO:0097090) | 2.88004806 |
| 110 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.87614447 |
| 111 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.87112365 |
| 112 | lymph vessel development (GO:0001945) | 2.86812210 |
| 113 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.86506581 |
| 114 | response to auditory stimulus (GO:0010996) | 2.84653342 |
| 115 | neutral lipid catabolic process (GO:0046461) | 2.84506730 |
| 116 | acylglycerol catabolic process (GO:0046464) | 2.84506730 |
| 117 | negative regulation of dendrite development (GO:2000171) | 2.83835307 |
| 118 | long term synaptic depression (GO:0060292) | 2.83785657 |
| 119 | potassium ion homeostasis (GO:0055075) | 2.83418372 |
| 120 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.82249052 |
| 121 | cellular response to cAMP (GO:0071320) | 2.77292172 |
| 122 | complement activation (GO:0006956) | 2.74529852 |
| 123 | negative regulation of epithelial cell migration (GO:0010633) | 2.74370247 |
| 124 | renal absorption (GO:0070293) | 2.73752468 |
| 125 | ovulation from ovarian follicle (GO:0001542) | 2.73594273 |
| 126 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.65943858 |
| 127 | cyclic purine nucleotide metabolic process (GO:0052652) | 2.62920999 |
| 128 | positive regulation of urine volume (GO:0035810) | 2.62098740 |
| 129 | cellular response to epinephrine stimulus (GO:0071872) | 2.60542802 |
| 130 | regulation of lipoprotein metabolic process (GO:0050746) | 2.59428897 |
| 131 | decidualization (GO:0046697) | 2.58929990 |
| 132 | regulation of macrophage chemotaxis (GO:0010758) | 2.56510313 |
| 133 | negative regulation of calcium ion transport (GO:0051926) | 2.55500552 |
| 134 | neuronal ion channel clustering (GO:0045161) | 2.54864436 |
| 135 | transcytosis (GO:0045056) | 2.53316230 |
| 136 | barbed-end actin filament capping (GO:0051016) | 2.50862887 |
| 137 | polyol transport (GO:0015791) | 2.50454387 |
| 138 | endocrine hormone secretion (GO:0060986) | 2.48729393 |
| 139 | endothelium development (GO:0003158) | 2.45130195 |
| 140 | cyclic nucleotide biosynthetic process (GO:0009190) | 2.45116232 |
| 141 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.44932921 |
| 142 | endothelial cell chemotaxis (GO:0035767) | 2.43654373 |
| 143 | protein heterotrimerization (GO:0070208) | 2.43478135 |
| 144 | extracellular fibril organization (GO:0043206) | 2.40117037 |
| 145 | cellular response to monoamine stimulus (GO:0071868) | 2.38874344 |
| 146 | cellular response to catecholamine stimulus (GO:0071870) | 2.38874344 |
| 147 | positive regulation of vascular permeability (GO:0043117) | 2.37319037 |
| 148 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.35133908 |
| 149 | virion attachment to host cell (GO:0019062) | 2.33220628 |
| 150 | adhesion of symbiont to host cell (GO:0044650) | 2.33220628 |
| 151 | cAMP metabolic process (GO:0046058) | 2.33088429 |
| 152 | glycerolipid catabolic process (GO:0046503) | 2.31834997 |
| 153 | regulation of glycogen (starch) synthase activity (GO:2000465) | 2.30963284 |
| 154 | extracellular matrix assembly (GO:0085029) | 2.29673917 |
| 155 | protein activation cascade (GO:0072376) | 2.29296259 |
| 156 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.29046960 |
| 157 | protein targeting to plasma membrane (GO:0072661) | 2.25956578 |
| 158 | actin filament capping (GO:0051693) | 2.23933452 |
| 159 | positive regulation of Rap GTPase activity (GO:0032854) | 2.22992635 |
| 160 | positive regulation of respiratory burst (GO:0060267) | 2.22336962 |
| 161 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.22271302 |
| 162 | regulation of calcium ion import (GO:0090279) | 2.20657676 |
| 163 | cellular sodium ion homeostasis (GO:0006883) | 2.20569592 |
| 164 | regulation of cardiac muscle contraction (GO:0055117) | 2.18981585 |
| 165 | regulation of vasculogenesis (GO:2001212) | 2.18127332 |
| 166 | blood vessel maturation (GO:0001955) | 2.17829213 |
| 167 | positive regulation of chemokine secretion (GO:0090197) | 2.15443427 |
| 168 | negative regulation of gluconeogenesis (GO:0045721) | 2.13904219 |
| 169 | gas transport (GO:0015669) | 2.13394301 |
| 170 | membrane repolarization (GO:0086009) | 2.13043408 |
| 171 | regulation of p38MAPK cascade (GO:1900744) | 2.12863647 |
| 172 | cellular response to nitric oxide (GO:0071732) | 2.12518576 |
| 173 | detection of calcium ion (GO:0005513) | 2.12351929 |
| 174 | regulation of Rap GTPase activity (GO:0032317) | 2.11870949 |
| 175 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.11747742 |
| 176 | negative regulation of actin filament bundle assembly (GO:0032232) | 2.10658438 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.11613780 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.47911913 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.23577249 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.22570714 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.97976553 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.83605030 |
| 7 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.82732701 |
| 8 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.76689400 |
| 9 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.76689400 |
| 10 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.64534469 |
| 11 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.64076727 |
| 12 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.62759841 |
| 13 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.61981915 |
| 14 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.60168551 |
| 15 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.58890584 |
| 16 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.47510021 |
| 17 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.46209561 |
| 18 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.41069317 |
| 19 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.38588967 |
| 20 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.38426397 |
| 21 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.21566959 |
| 22 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.20074252 |
| 23 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.19646992 |
| 24 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.17661630 |
| 25 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.12208578 |
| 26 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.10761353 |
| 27 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.08961643 |
| 28 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.06688583 |
| 29 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.99223258 |
| 30 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.85990138 |
| 31 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.75172101 |
| 32 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.74403340 |
| 33 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.72349851 |
| 34 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.72040522 |
| 35 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.71250869 |
| 36 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.70595576 |
| 37 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.67859507 |
| 38 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.66834062 |
| 39 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.66624939 |
| 40 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.63727132 |
| 41 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.60490596 |
| 42 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.58614441 |
| 43 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.54364857 |
| 44 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.54015533 |
| 45 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.53834963 |
| 46 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.53107550 |
| 47 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.49135175 |
| 48 | P300_19829295_ChIP-Seq_ESCs_Human | 1.46301898 |
| 49 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.41520589 |
| 50 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.41491794 |
| 51 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.38130707 |
| 52 | GATA1_22025678_ChIP-Seq_K562_Human | 1.37453071 |
| 53 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.36475999 |
| 54 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.35727995 |
| 55 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.29923187 |
| 56 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.29374376 |
| 57 | AR_25329375_ChIP-Seq_VCAP_Human | 1.28682675 |
| 58 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.26324123 |
| 59 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.25887337 |
| 60 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.25639530 |
| 61 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.25439965 |
| 62 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.25235660 |
| 63 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.24875980 |
| 64 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.23644975 |
| 65 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.23242939 |
| 66 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.23139386 |
| 67 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.22976053 |
| 68 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.22438388 |
| 69 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.21684762 |
| 70 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.18427506 |
| 71 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.17454381 |
| 72 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.17144558 |
| 73 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.15661171 |
| 74 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.15661171 |
| 75 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.15108208 |
| 76 | STAT3_23295773_ChIP-Seq_U87_Human | 1.14516288 |
| 77 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.14383599 |
| 78 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.14224152 |
| 79 | AR_19668381_ChIP-Seq_PC3_Human | 1.13279693 |
| 80 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.12529293 |
| 81 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.11588735 |
| 82 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.10962078 |
| 83 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.10911435 |
| 84 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.09883174 |
| 85 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.08441889 |
| 86 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.06292613 |
| 87 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.05668146 |
| 88 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04772317 |
| 89 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.04634664 |
| 90 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.04401179 |
| 91 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.03559000 |
| 92 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.02816850 |
| 93 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.02457363 |
| 94 | KDM2B_26808549_Chip-Seq_K562_Human | 1.02211280 |
| 95 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.01780882 |
| 96 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.00936275 |
| 97 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.00588437 |
| 98 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.00574206 |
| 99 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.00111014 |
| 100 | GATA1_19941826_ChIP-Seq_K562_Human | 0.99758736 |
| 101 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.99047694 |
| 102 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.98722852 |
| 103 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.98288713 |
| 104 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98175440 |
| 105 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.95457151 |
| 106 | TCF4_23295773_ChIP-Seq_U87_Human | 0.95372625 |
| 107 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.94230401 |
| 108 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.93352366 |
| 109 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.93275556 |
| 110 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.93101754 |
| 111 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.91944382 |
| 112 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.91750276 |
| 113 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.91375747 |
| 114 | CJUN_26792858_Chip-Seq_BT549_Human | 0.91302259 |
| 115 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91104004 |
| 116 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.90616567 |
| 117 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.90177412 |
| 118 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.89544926 |
| 119 | RXR_22108803_ChIP-Seq_LS180_Human | 0.89505016 |
| 120 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.89202181 |
| 121 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.89061716 |
| 122 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.87642299 |
| 123 | VDR_22108803_ChIP-Seq_LS180_Human | 0.87636588 |
| 124 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.87017666 |
| 125 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.85682369 |
| 126 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.84753160 |
| 127 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.84446935 |
| 128 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.83945132 |
| 129 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.83700179 |
| 130 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.83336182 |
| 131 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.82491141 |
| 132 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.82230457 |
| 133 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.81975285 |
| 134 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.81975285 |
| 135 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.81300050 |
| 136 | JUN_21703547_ChIP-Seq_K562_Human | 0.81106594 |
| 137 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.80747392 |
| 138 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.80542120 |
| 139 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.80467324 |
| 140 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.80060985 |
| 141 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.78799472 |
| 142 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.78249769 |
| 143 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.78171922 |
| 144 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.78171836 |
| 145 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.77805937 |
| 146 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.75148749 |
| 147 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.74257243 |
| 148 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.74156437 |
| 149 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.73296067 |
| 150 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.73057582 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.35752694 |
| 2 | MP0003880_abnormal_central_pattern | 4.62878271 |
| 3 | MP0005670_abnormal_white_adipose | 4.28908072 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 3.74505639 |
| 5 | MP0003011_delayed_dark_adaptation | 3.57015448 |
| 6 | MP0004270_analgesia | 3.47872281 |
| 7 | MP0001968_abnormal_touch/_nociception | 3.28112561 |
| 8 | MP0009046_muscle_twitch | 3.21737191 |
| 9 | MP0009745_abnormal_behavioral_response | 2.99260308 |
| 10 | MP0002735_abnormal_chemical_nociception | 2.98662903 |
| 11 | MP0002063_abnormal_learning/memory/cond | 2.87709839 |
| 12 | MP0002734_abnormal_mechanical_nocicepti | 2.85311531 |
| 13 | MP0002064_seizures | 2.83053518 |
| 14 | MP0002736_abnormal_nociception_after | 2.75499124 |
| 15 | MP0002272_abnormal_nervous_system | 2.62812004 |
| 16 | MP0005275_abnormal_skin_tensile | 2.57146108 |
| 17 | MP0002572_abnormal_emotion/affect_behav | 2.47657390 |
| 18 | MP0005423_abnormal_somatic_nervous | 2.45415399 |
| 19 | MP0002067_abnormal_sensory_capabilities | 2.33729561 |
| 20 | MP0005666_abnormal_adipose_tissue | 2.30054565 |
| 21 | MP0010368_abnormal_lymphatic_system | 2.29659642 |
| 22 | MP0000013_abnormal_adipose_tissue | 2.29643311 |
| 23 | MP0001486_abnormal_startle_reflex | 2.24207657 |
| 24 | MP0002971_abnormal_brown_adipose | 2.23161517 |
| 25 | MP0006276_abnormal_autonomic_nervous | 2.21103968 |
| 26 | MP0006138_congestive_heart_failure | 2.21014192 |
| 27 | MP0001501_abnormal_sleep_pattern | 2.16364931 |
| 28 | MP0001440_abnormal_grooming_behavior | 2.15186288 |
| 29 | MP0002184_abnormal_innervation | 2.09597954 |
| 30 | MP0002733_abnormal_thermal_nociception | 2.07116506 |
| 31 | MP0008438_abnormal_cutaneous_collagen | 2.01583530 |
| 32 | MP0005503_abnormal_tendon_morphology | 2.00102947 |
| 33 | MP0001970_abnormal_pain_threshold | 1.99205855 |
| 34 | MP0004147_increased_porphyrin_level | 1.97478776 |
| 35 | MP0008569_lethality_at_weaning | 1.95109991 |
| 36 | MP0004858_abnormal_nervous_system | 1.93871020 |
| 37 | MP0008004_abnormal_stomach_pH | 1.93237567 |
| 38 | MP0005551_abnormal_eye_electrophysiolog | 1.82831356 |
| 39 | MP0001984_abnormal_olfaction | 1.80755677 |
| 40 | MP0003724_increased_susceptibility_to | 1.80468091 |
| 41 | MP0005375_adipose_tissue_phenotype | 1.79059983 |
| 42 | MP0000778_abnormal_nervous_system | 1.76095461 |
| 43 | MP0002822_catalepsy | 1.76024631 |
| 44 | MP0001879_abnormal_lymphatic_vessel | 1.74372675 |
| 45 | MP0002876_abnormal_thyroid_physiology | 1.70624225 |
| 46 | MP0004924_abnormal_behavior | 1.69041741 |
| 47 | MP0005386_behavior/neurological_phenoty | 1.69041741 |
| 48 | MP0004215_abnormal_myocardial_fiber | 1.68626945 |
| 49 | MP0003279_aneurysm | 1.61654942 |
| 50 | MP0004811_abnormal_neuron_physiology | 1.61234262 |
| 51 | MP0002557_abnormal_social/conspecific_i | 1.59093757 |
| 52 | MP0003329_amyloid_beta_deposits | 1.58907588 |
| 53 | MP0000955_abnormal_spinal_cord | 1.55871098 |
| 54 | MP0004145_abnormal_muscle_electrophysio | 1.51212305 |
| 55 | MP0002909_abnormal_adrenal_gland | 1.48439524 |
| 56 | MP0000343_altered_response_to | 1.48160644 |
| 57 | MP0001502_abnormal_circadian_rhythm | 1.46934377 |
| 58 | MP0003633_abnormal_nervous_system | 1.43118192 |
| 59 | MP0009115_abnormal_fat_cell | 1.40655208 |
| 60 | MP0001958_emphysema | 1.40375013 |
| 61 | MP0003828_pulmonary_edema | 1.39638828 |
| 62 | MP0002882_abnormal_neuron_morphology | 1.39524483 |
| 63 | MP0009379_abnormal_foot_pigmentation | 1.36717906 |
| 64 | MP0001188_hyperpigmentation | 1.35734110 |
| 65 | MP0003879_abnormal_hair_cell | 1.34806593 |
| 66 | MP0002066_abnormal_motor_capabilities/c | 1.34012470 |
| 67 | MP0004142_abnormal_muscle_tone | 1.28700358 |
| 68 | MP0006054_spinal_hemorrhage | 1.28143090 |
| 69 | MP0001544_abnormal_cardiovascular_syste | 1.27973592 |
| 70 | MP0005385_cardiovascular_system_phenoty | 1.27973592 |
| 71 | MP0001529_abnormal_vocalization | 1.27347219 |
| 72 | MP0010329_abnormal_lipoprotein_level | 1.22476036 |
| 73 | MP0002295_abnormal_pulmonary_circulatio | 1.19874307 |
| 74 | MP0003959_abnormal_lean_body | 1.19598029 |
| 75 | MP0002933_joint_inflammation | 1.18248349 |
| 76 | MP0005448_abnormal_energy_balance | 1.18165316 |
| 77 | MP0005409_darkened_coat_color | 1.17662343 |
| 78 | MP0000249_abnormal_blood_vessel | 1.17480429 |
| 79 | MP0003045_fibrosis | 1.16634597 |
| 80 | MP0003631_nervous_system_phenotype | 1.15810436 |
| 81 | MP0002108_abnormal_muscle_morphology | 1.13456455 |
| 82 | MP0009780_abnormal_chondrocyte_physiolo | 1.12396380 |
| 83 | MP0003075_altered_response_to | 1.12070680 |
| 84 | MP0000767_abnormal_smooth_muscle | 1.10802599 |
| 85 | MP0002229_neurodegeneration | 1.08595000 |
| 86 | MP0005166_decreased_susceptibility_to | 1.07423678 |
| 87 | MP0005083_abnormal_biliary_tract | 1.06301938 |
| 88 | MP0000751_myopathy | 1.05261082 |
| 89 | MP0005334_abnormal_fat_pad | 1.05188639 |
| 90 | MP0002090_abnormal_vision | 1.02135780 |
| 91 | MP0004085_abnormal_heartbeat | 1.01180257 |
| 92 | MP0002638_abnormal_pupillary_reflex | 1.01030237 |
| 93 | MP0003303_peritoneal_inflammation | 1.00713658 |
| 94 | MP0000003_abnormal_adipose_tissue | 1.00058097 |
| 95 | MP0001905_abnormal_dopamine_level | 0.99920137 |
| 96 | MP0008874_decreased_physiological_sensi | 0.99649932 |
| 97 | MP0005620_abnormal_muscle_contractility | 0.98513684 |
| 98 | MP0004885_abnormal_endolymph | 0.98197875 |
| 99 | MP0002152_abnormal_brain_morphology | 0.96959899 |
| 100 | MP0001851_eye_inflammation | 0.96680851 |
| 101 | MP0002972_abnormal_cardiac_muscle | 0.95044053 |
| 102 | MP0004742_abnormal_vestibular_system | 0.95005030 |
| 103 | MP0008872_abnormal_physiological_respon | 0.94869983 |
| 104 | MP0002752_abnormal_somatic_nervous | 0.91703811 |
| 105 | MP0006072_abnormal_retinal_apoptosis | 0.90120923 |
| 106 | MP0005167_abnormal_blood-brain_barrier | 0.88139487 |
| 107 | MP0005394_taste/olfaction_phenotype | 0.88118215 |
| 108 | MP0005499_abnormal_olfactory_system | 0.88118215 |
| 109 | MP0004084_abnormal_cardiac_muscle | 0.87490125 |
| 110 | MP0003122_maternal_imprinting | 0.86865954 |
| 111 | MP0002118_abnormal_lipid_homeostasis | 0.86014685 |
| 112 | MP0005646_abnormal_pituitary_gland | 0.83697513 |
| 113 | MP0003634_abnormal_glial_cell | 0.83234651 |
| 114 | MP0005165_increased_susceptibility_to | 0.83133809 |
| 115 | MP0003787_abnormal_imprinting | 0.82942823 |
| 116 | MP0002970_abnormal_white_adipose | 0.81323674 |
| 117 | MP0002133_abnormal_respiratory_system | 0.81016316 |
| 118 | MP0005388_respiratory_system_phenotype | 0.81016316 |
| 119 | MP0010386_abnormal_urinary_bladder | 0.80592989 |
| 120 | MP0003948_abnormal_gas_homeostasis | 0.79900751 |
| 121 | MP0000747_muscle_weakness | 0.79602605 |
| 122 | MP0004510_myositis | 0.79567969 |
| 123 | MP0002069_abnormal_eating/drinking_beha | 0.74988606 |
| 124 | MP0000230_abnormal_systemic_arterial | 0.74536777 |
| 125 | MP0003632_abnormal_nervous_system | 0.74130830 |
| 126 | MP0003868_abnormal_feces_composition | 0.74079973 |
| 127 | MP0000749_muscle_degeneration | 0.73996484 |
| 128 | MP0000604_amyloidosis | 0.73236304 |
| 129 | MP0005253_abnormal_eye_physiology | 0.71962758 |
| 130 | MP0004087_abnormal_muscle_fiber | 0.71401994 |
| 131 | MP0002332_abnormal_exercise_endurance | 0.70318017 |
| 132 | MP0000920_abnormal_myelination | 0.70268913 |
| 133 | MP0005645_abnormal_hypothalamus_physiol | 0.69315634 |
| 134 | MP0004130_abnormal_muscle_cell | 0.68685686 |
| 135 | MP0005535_abnormal_body_temperature | 0.67979209 |
| 136 | MP0001177_atelectasis | 0.67398457 |
| 137 | MP0001963_abnormal_hearing_physiology | 0.66872406 |
| 138 | MP0005623_abnormal_meninges_morphology | 0.63507739 |
| 139 | MP0005195_abnormal_posterior_eye | 0.62967572 |
| 140 | MP0003137_abnormal_impulse_conducting | 0.62462463 |
| 141 | MP0004233_abnormal_muscle_weight | 0.59490763 |
| 142 | MP0003690_abnormal_glial_cell | 0.59121142 |
| 143 | MP0005595_abnormal_vascular_smooth | 0.55136394 |
| 144 | MP0002089_abnormal_postnatal_growth/wei | 0.54543536 |
| 145 | MP0004484_altered_response_of | 0.54205762 |
| 146 | MP0004036_abnormal_muscle_relaxation | 0.53934249 |
| 147 | MP0010770_preweaning_lethality | 0.53914228 |
| 148 | MP0002082_postnatal_lethality | 0.53914228 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 6.54638835 |
| 2 | Myokymia (HP:0002411) | 6.28576367 |
| 3 | Focal seizures (HP:0007359) | 5.19279017 |
| 4 | Visual hallucinations (HP:0002367) | 5.03453188 |
| 5 | Febrile seizures (HP:0002373) | 5.02043234 |
| 6 | Epileptic encephalopathy (HP:0200134) | 4.98712237 |
| 7 | Atonic seizures (HP:0010819) | 4.84329549 |
| 8 | Complement deficiency (HP:0004431) | 4.74800872 |
| 9 | Systemic lupus erythematosus (HP:0002725) | 4.71386658 |
| 10 | Progressive cerebellar ataxia (HP:0002073) | 4.66719077 |
| 11 | Muscle fiber splitting (HP:0003555) | 4.22834620 |
| 12 | Action tremor (HP:0002345) | 4.19545243 |
| 13 | Abnormality of complement system (HP:0005339) | 4.19168919 |
| 14 | Absence seizures (HP:0002121) | 4.15730085 |
| 15 | Supranuclear gaze palsy (HP:0000605) | 3.72133410 |
| 16 | Pigmentary retinal degeneration (HP:0001146) | 3.71365211 |
| 17 | Generalized tonic-clonic seizures (HP:0002069) | 3.65668817 |
| 18 | Dialeptic seizures (HP:0011146) | 3.61422206 |
| 19 | Oligomenorrhea (HP:0000876) | 3.49613289 |
| 20 | Central scotoma (HP:0000603) | 3.46918090 |
| 21 | Aortic aneurysm (HP:0004942) | 3.38380292 |
| 22 | Cerebral aneurysm (HP:0004944) | 3.32945638 |
| 23 | Gaze-evoked nystagmus (HP:0000640) | 3.26662444 |
| 24 | Amyloidosis (HP:0011034) | 3.24752753 |
| 25 | Hyporeflexia of lower limbs (HP:0002600) | 3.24007229 |
| 26 | Congenital stationary night blindness (HP:0007642) | 3.23838996 |
| 27 | Glomerulonephritis (HP:0000099) | 3.21514056 |
| 28 | Vascular tortuosity (HP:0004948) | 3.19271859 |
| 29 | Broad-based gait (HP:0002136) | 3.18662041 |
| 30 | Difficulty running (HP:0009046) | 3.12321282 |
| 31 | Acanthosis nigricans (HP:0000956) | 3.11932100 |
| 32 | Depression (HP:0000716) | 3.04137704 |
| 33 | Mutism (HP:0002300) | 3.00824867 |
| 34 | Obstructive sleep apnea (HP:0002870) | 3.00549111 |
| 35 | Hypertriglyceridemia (HP:0002155) | 3.00517412 |
| 36 | Abnormality of the foot musculature (HP:0001436) | 2.99968708 |
| 37 | Ankle clonus (HP:0011448) | 2.94539243 |
| 38 | Hyperventilation (HP:0002883) | 2.93911579 |
| 39 | Foot dorsiflexor weakness (HP:0009027) | 2.92790305 |
| 40 | Dysdiadochokinesis (HP:0002075) | 2.92173429 |
| 41 | Polycythemia (HP:0001901) | 2.90531476 |
| 42 | Poor eye contact (HP:0000817) | 2.90283794 |
| 43 | Arterial tortuosity (HP:0005116) | 2.89264322 |
| 44 | Truncal ataxia (HP:0002078) | 2.89140348 |
| 45 | Increased connective tissue (HP:0009025) | 2.85952166 |
| 46 | Anxiety (HP:0000739) | 2.82686595 |
| 47 | Abnormality of macular pigmentation (HP:0008002) | 2.82025541 |
| 48 | Amblyopia (HP:0000646) | 2.81961942 |
| 49 | Abnormality of the lower motor neuron (HP:0002366) | 2.81590622 |
| 50 | Pheochromocytoma (HP:0002666) | 2.80590415 |
| 51 | Bundle branch block (HP:0011710) | 2.78739413 |
| 52 | Limb dystonia (HP:0002451) | 2.78079220 |
| 53 | Termporal pattern (HP:0011008) | 2.75986815 |
| 54 | Insidious onset (HP:0003587) | 2.75986815 |
| 55 | Increased variability in muscle fiber diameter (HP:0003557) | 2.72185103 |
| 56 | Abnormal eating behavior (HP:0100738) | 2.71697852 |
| 57 | Abnormal social behavior (HP:0012433) | 2.70038217 |
| 58 | Impaired social interactions (HP:0000735) | 2.70038217 |
| 59 | Nonimmune hydrops fetalis (HP:0001790) | 2.69418576 |
| 60 | Dysmetria (HP:0001310) | 2.69175181 |
| 61 | Hemiparesis (HP:0001269) | 2.67930141 |
| 62 | Scanning speech (HP:0002168) | 2.63844117 |
| 63 | Axonal loss (HP:0003447) | 2.58622201 |
| 64 | Hemiplegia (HP:0002301) | 2.57731841 |
| 65 | Impaired smooth pursuit (HP:0007772) | 2.57620809 |
| 66 | Striae distensae (HP:0001065) | 2.56269030 |
| 67 | Growth hormone excess (HP:0000845) | 2.56162257 |
| 68 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.54167733 |
| 69 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.53936093 |
| 70 | Abnormality of the corticospinal tract (HP:0002492) | 2.52880204 |
| 71 | Sudden death (HP:0001699) | 2.47304223 |
| 72 | Genetic anticipation (HP:0003743) | 2.46534067 |
| 73 | Abnormality of binocular vision (HP:0011514) | 2.43264842 |
| 74 | Diplopia (HP:0000651) | 2.43264842 |
| 75 | Neuroendocrine neoplasm (HP:0100634) | 2.43079194 |
| 76 | Protrusio acetabuli (HP:0003179) | 2.42388393 |
| 77 | Fetal akinesia sequence (HP:0001989) | 2.41245587 |
| 78 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.40291074 |
| 79 | Excessive salivation (HP:0003781) | 2.40172294 |
| 80 | Drooling (HP:0002307) | 2.40172294 |
| 81 | Dysmetric saccades (HP:0000641) | 2.39196811 |
| 82 | Torticollis (HP:0000473) | 2.38891478 |
| 83 | Scotoma (HP:0000575) | 2.37929035 |
| 84 | Type 1 muscle fiber predominance (HP:0003803) | 2.36360324 |
| 85 | Prolonged QT interval (HP:0001657) | 2.32571515 |
| 86 | Peripheral hypomyelination (HP:0007182) | 2.32343573 |
| 87 | Polyphagia (HP:0002591) | 2.32151228 |
| 88 | Hyperlipoproteinemia (HP:0010980) | 2.31358445 |
| 89 | Abnormal atrioventricular conduction (HP:0005150) | 2.29208427 |
| 90 | Epileptiform EEG discharges (HP:0011182) | 2.28725070 |
| 91 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.28660734 |
| 92 | Syncope (HP:0001279) | 2.27155265 |
| 93 | Nephritis (HP:0000123) | 2.26239052 |
| 94 | Spastic gait (HP:0002064) | 2.26019571 |
| 95 | Focal dystonia (HP:0004373) | 2.25430863 |
| 96 | Heart block (HP:0012722) | 2.24742090 |
| 97 | Abnormal gallbladder physiology (HP:0012438) | 2.24438580 |
| 98 | Cholecystitis (HP:0001082) | 2.24438580 |
| 99 | Primary atrial arrhythmia (HP:0001692) | 2.24312170 |
| 100 | Agitation (HP:0000713) | 2.24033210 |
| 101 | Neurofibrillary tangles (HP:0002185) | 2.23917821 |
| 102 | EEG with generalized epileptiform discharges (HP:0011198) | 2.23707617 |
| 103 | Atrial fibrillation (HP:0005110) | 2.22671028 |
| 104 | Intention tremor (HP:0002080) | 2.20901700 |
| 105 | Progressive inability to walk (HP:0002505) | 2.18283211 |
| 106 | Ventricular fibrillation (HP:0001663) | 2.17860872 |
| 107 | Status epilepticus (HP:0002133) | 2.16532357 |
| 108 | Incomplete penetrance (HP:0003829) | 2.15531705 |
| 109 | Broad metatarsal (HP:0001783) | 2.14690295 |
| 110 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.12876779 |
| 111 | Supraventricular arrhythmia (HP:0005115) | 2.12560872 |
| 112 | Pulmonary artery stenosis (HP:0004415) | 2.12420956 |
| 113 | Supraventricular tachycardia (HP:0004755) | 2.12298155 |
| 114 | Hypoventilation (HP:0002791) | 2.10777764 |
| 115 | Craniofacial dystonia (HP:0012179) | 2.10524290 |
| 116 | Postural instability (HP:0002172) | 2.10491920 |
| 117 | Cerebral inclusion bodies (HP:0100314) | 2.10337416 |
| 118 | Failure to thrive in infancy (HP:0001531) | 2.10213614 |
| 119 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.10160624 |
| 120 | Urinary urgency (HP:0000012) | 2.09913212 |
| 121 | Absent speech (HP:0001344) | 2.09344500 |
| 122 | Spinal canal stenosis (HP:0003416) | 2.08827773 |
| 123 | Steppage gait (HP:0003376) | 2.08319053 |
| 124 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.07311266 |
| 125 | Papilledema (HP:0001085) | 2.06744704 |
| 126 | Aortic dissection (HP:0002647) | 2.06120291 |
| 127 | Ulnar claw (HP:0001178) | 2.05332799 |
| 128 | Asymmetric septal hypertrophy (HP:0001670) | 2.03332880 |
| 129 | Overgrowth (HP:0001548) | 2.03106365 |
| 130 | Hypsarrhythmia (HP:0002521) | 2.02764621 |
| 131 | Amyotrophic lateral sclerosis (HP:0007354) | 2.01494305 |
| 132 | Stereotypic behavior (HP:0000733) | 2.01283324 |
| 133 | Bradykinesia (HP:0002067) | 2.00810996 |
| 134 | Increased IgE level (HP:0003212) | 2.00676257 |
| 135 | Severe visual impairment (HP:0001141) | 1.99610275 |
| 136 | Metaphyseal dysplasia (HP:0100255) | 1.97306658 |
| 137 | Inability to walk (HP:0002540) | 1.96393609 |
| 138 | Lower limb muscle weakness (HP:0007340) | 1.96194437 |
| 139 | Onion bulb formation (HP:0003383) | 1.95174988 |
| 140 | Bone cyst (HP:0012062) | 1.93551568 |
| 141 | Atelectasis (HP:0100750) | 1.93496653 |
| 142 | Hypercortisolism (HP:0001578) | 1.91667230 |
| 143 | Spontaneous hematomas (HP:0007420) | 1.91067731 |
| 144 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.90877615 |
| 145 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.89450656 |
| 146 | Rapidly progressive (HP:0003678) | 1.89304539 |
| 147 | Neck muscle weakness (HP:0000467) | 1.88649745 |
| 148 | Gait imbalance (HP:0002141) | 1.88416727 |
| 149 | Cerebral hemorrhage (HP:0001342) | 1.88025266 |
| 150 | Absent eyebrow (HP:0002223) | 1.88014584 |
| 151 | EMG: neuropathic changes (HP:0003445) | 1.87481185 |
| 152 | Distal lower limb muscle weakness (HP:0009053) | 1.86780871 |
| 153 | Malnutrition (HP:0004395) | 1.86710631 |
| 154 | Myotonia (HP:0002486) | 1.86028235 |
| 155 | Postural tremor (HP:0002174) | 1.85906095 |
| 156 | Atrioventricular block (HP:0001678) | 1.85620295 |
| 157 | Retinal dysplasia (HP:0007973) | 1.85046025 |
| 158 | Decreased central vision (HP:0007663) | 1.84658694 |
| 159 | Choroideremia (HP:0001139) | 1.84450798 |
| 160 | Wormian bones (HP:0002645) | 1.83673170 |
| 161 | Stroke (HP:0001297) | 1.83494841 |
| 162 | Impaired pain sensation (HP:0007328) | 1.82925285 |
| 163 | Abnormality of pain sensation (HP:0010832) | 1.82925285 |
| 164 | Hammertoe (HP:0001765) | 1.82858706 |
| 165 | Bulbar palsy (HP:0001283) | 1.82738439 |
| 166 | Generalized myoclonic seizures (HP:0002123) | 1.82404536 |
| 167 | Gait ataxia (HP:0002066) | 1.82154909 |
| 168 | Abnormal EKG (HP:0003115) | 1.81775031 |
| 169 | Specific learning disability (HP:0001328) | 1.81232483 |
| 170 | Abnormal hair whorl (HP:0010721) | 1.80432764 |
| 171 | Persistence of primary teeth (HP:0006335) | 1.80322802 |
| 172 | Lower limb amyotrophy (HP:0007210) | 1.78951083 |
| 173 | Lipoatrophy (HP:0100578) | 1.77299193 |
| 174 | Ventricular arrhythmia (HP:0004308) | 1.77221798 |
| 175 | Nuclear cataract (HP:0100018) | 1.75753548 |
| 176 | Ileus (HP:0002595) | 1.75120443 |
| 177 | Aneurysm (HP:0002617) | 1.72493299 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KDR | 4.78474628 |
| 2 | NTRK3 | 3.62110478 |
| 3 | MARK1 | 3.39772716 |
| 4 | MAP3K9 | 3.04522726 |
| 5 | EPHA3 | 2.99435290 |
| 6 | MAP3K4 | 2.91784003 |
| 7 | MINK1 | 2.88224790 |
| 8 | TIE1 | 2.71350470 |
| 9 | CASK | 2.70605207 |
| 10 | DAPK2 | 2.69646165 |
| 11 | MAP2K7 | 2.39448871 |
| 12 | EPHB2 | 2.35538839 |
| 13 | MAP3K12 | 2.31128921 |
| 14 | EPHA4 | 2.29578081 |
| 15 | PAK6 | 2.10571835 |
| 16 | MAP2K4 | 2.02833433 |
| 17 | MYLK | 2.01240122 |
| 18 | CAMKK2 | 1.90574912 |
| 19 | ERN1 | 1.81527787 |
| 20 | MAPK13 | 1.69435768 |
| 21 | GRK5 | 1.67823948 |
| 22 | DDR2 | 1.64657715 |
| 23 | EPHB1 | 1.63191380 |
| 24 | KSR2 | 1.62507721 |
| 25 | CAMKK1 | 1.57906387 |
| 26 | SIK2 | 1.54170887 |
| 27 | NTRK1 | 1.53103889 |
| 28 | NTRK2 | 1.53010974 |
| 29 | MAP3K6 | 1.51734892 |
| 30 | PLK2 | 1.47533826 |
| 31 | PRPF4B | 1.43501013 |
| 32 | PHKG1 | 1.38860224 |
| 33 | PHKG2 | 1.38860224 |
| 34 | FES | 1.37112329 |
| 35 | CDK5 | 1.35407926 |
| 36 | PNCK | 1.33749680 |
| 37 | PTK2 | 1.29320511 |
| 38 | DAPK1 | 1.27327315 |
| 39 | PDGFRA | 1.18195599 |
| 40 | PRKCG | 1.16774476 |
| 41 | ITK | 1.15313486 |
| 42 | SGK494 | 1.13681009 |
| 43 | SGK223 | 1.13681009 |
| 44 | TEC | 1.13304429 |
| 45 | NLK | 1.10827855 |
| 46 | RIPK1 | 1.08191577 |
| 47 | ABL2 | 1.07210150 |
| 48 | CAMK4 | 1.06710356 |
| 49 | PTK2B | 1.04703231 |
| 50 | CDK19 | 1.04320477 |
| 51 | TTN | 1.02572508 |
| 52 | SIK3 | 1.01889282 |
| 53 | RET | 0.99197387 |
| 54 | CAMK2A | 0.98673116 |
| 55 | CDC42BPA | 0.97532931 |
| 56 | KSR1 | 0.96345981 |
| 57 | PRKD3 | 0.95736841 |
| 58 | PRKAA2 | 0.93183372 |
| 59 | TNIK | 0.93048601 |
| 60 | MAPK4 | 0.92767772 |
| 61 | MAPKAPK3 | 0.92431516 |
| 62 | FGFR4 | 0.91967314 |
| 63 | TRPM7 | 0.91809800 |
| 64 | STK38 | 0.90026205 |
| 65 | SGK2 | 0.88727231 |
| 66 | LATS2 | 0.87808843 |
| 67 | MAPK7 | 0.87404113 |
| 68 | TBK1 | 0.86236091 |
| 69 | PRKCH | 0.85008245 |
| 70 | RIPK4 | 0.84079752 |
| 71 | DYRK1A | 0.83824392 |
| 72 | PRKD1 | 0.83541753 |
| 73 | MAP3K2 | 0.83307237 |
| 74 | DMPK | 0.83291103 |
| 75 | CDK14 | 0.81746779 |
| 76 | MAPK12 | 0.81274746 |
| 77 | ARAF | 0.81023708 |
| 78 | CDK18 | 0.80835360 |
| 79 | TGFBR1 | 0.79911150 |
| 80 | TRIB3 | 0.79094192 |
| 81 | FER | 0.77985500 |
| 82 | UHMK1 | 0.77710927 |
| 83 | CDK15 | 0.77197041 |
| 84 | PDGFRB | 0.76875092 |
| 85 | NEK1 | 0.76410189 |
| 86 | TYRO3 | 0.76191619 |
| 87 | PKN1 | 0.75062077 |
| 88 | GRK7 | 0.74968458 |
| 89 | BMPR2 | 0.73049118 |
| 90 | ROCK1 | 0.70787623 |
| 91 | CSNK1G2 | 0.70573580 |
| 92 | MAP2K1 | 0.69708794 |
| 93 | TAOK1 | 0.66140451 |
| 94 | TESK1 | 0.65751037 |
| 95 | CDK11A | 0.65710551 |
| 96 | CAMK1 | 0.63938072 |
| 97 | CSK | 0.63649193 |
| 98 | ERBB3 | 0.63513018 |
| 99 | MAPK10 | 0.62750593 |
| 100 | CAMK1G | 0.61235864 |
| 101 | LMTK2 | 0.61180429 |
| 102 | STK11 | 0.60422196 |
| 103 | HIPK2 | 0.60114486 |
| 104 | SGK3 | 0.59728577 |
| 105 | PINK1 | 0.59126683 |
| 106 | CAMK2B | 0.59055624 |
| 107 | WNK1 | 0.58089963 |
| 108 | TYK2 | 0.57782402 |
| 109 | EEF2K | 0.57624126 |
| 110 | AKT3 | 0.55969261 |
| 111 | PRKCE | 0.55842086 |
| 112 | ACVR1B | 0.54536763 |
| 113 | SIK1 | 0.54054434 |
| 114 | STK39 | 0.53467519 |
| 115 | OXSR1 | 0.52247724 |
| 116 | PRKCZ | 0.50671999 |
| 117 | PRKAA1 | 0.50452323 |
| 118 | SGK1 | 0.49909831 |
| 119 | GRK1 | 0.49876579 |
| 120 | PRKG1 | 0.49258730 |
| 121 | TNK2 | 0.48779687 |
| 122 | KIT | 0.48538698 |
| 123 | FGFR3 | 0.48387998 |
| 124 | PRKACG | 0.48362372 |
| 125 | MARK2 | 0.47713759 |
| 126 | PDPK1 | 0.47090925 |
| 127 | PRKG2 | 0.46840634 |
| 128 | MAP3K13 | 0.46500160 |
| 129 | RPS6KA2 | 0.45882081 |
| 130 | MAP3K1 | 0.45579695 |
| 131 | PAK3 | 0.44924147 |
| 132 | NME1 | 0.44858942 |
| 133 | JAK1 | 0.43858103 |
| 134 | CAMK2G | 0.43690651 |
| 135 | CAMK2D | 0.41690761 |
| 136 | CCNB1 | 0.41454368 |
| 137 | SCYL2 | 0.40727388 |
| 138 | JAK2 | 0.40726462 |
| 139 | ADRBK1 | 0.39500207 |
| 140 | RPS6KA3 | 0.36781470 |
| 141 | FYN | 0.34907084 |
| 142 | TGFBR2 | 0.32634798 |
| 143 | PRKACA | 0.32498876 |
| 144 | SRC | 0.31238890 |
| 145 | ROCK2 | 0.30765723 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.84274547 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.70705283 |
| 3 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.83403054 |
| 4 | GABAergic synapse_Homo sapiens_hsa04727 | 2.78654486 |
| 5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.60157660 |
| 6 | Olfactory transduction_Homo sapiens_hsa04740 | 2.57653673 |
| 7 | Morphine addiction_Homo sapiens_hsa05032 | 2.51999770 |
| 8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.50915742 |
| 9 | Long-term potentiation_Homo sapiens_hsa04720 | 2.30786235 |
| 10 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.22123130 |
| 11 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.08184077 |
| 12 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.06036399 |
| 13 | Salivary secretion_Homo sapiens_hsa04970 | 2.05615956 |
| 14 | Taste transduction_Homo sapiens_hsa04742 | 1.98972891 |
| 15 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.94697017 |
| 16 | Insulin secretion_Homo sapiens_hsa04911 | 1.91950243 |
| 17 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.91207867 |
| 18 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.87220477 |
| 19 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.85480587 |
| 20 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.81991068 |
| 21 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.71865395 |
| 22 | Renin secretion_Homo sapiens_hsa04924 | 1.71575052 |
| 23 | Long-term depression_Homo sapiens_hsa04730 | 1.67363041 |
| 24 | Phototransduction_Homo sapiens_hsa04744 | 1.66163269 |
| 25 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.65505007 |
| 26 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.62643987 |
| 27 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.57657635 |
| 28 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.57356658 |
| 29 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.54382863 |
| 30 | Cocaine addiction_Homo sapiens_hsa05030 | 1.49517582 |
| 31 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.41145113 |
| 32 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.40024043 |
| 33 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.34755231 |
| 34 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.32755170 |
| 35 | Gap junction_Homo sapiens_hsa04540 | 1.31210790 |
| 36 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.28871375 |
| 37 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.26065863 |
| 38 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.25594293 |
| 39 | Histidine metabolism_Homo sapiens_hsa00340 | 1.22615604 |
| 40 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.20394783 |
| 41 | Axon guidance_Homo sapiens_hsa04360 | 1.18661271 |
| 42 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.18522834 |
| 43 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.17772919 |
| 44 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.17321511 |
| 45 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.16126407 |
| 46 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.09109414 |
| 47 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.08095710 |
| 48 | * Malaria_Homo sapiens_hsa05144 | 1.07978930 |
| 49 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.04704064 |
| 50 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.01078404 |
| 51 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.00614730 |
| 52 | Mineral absorption_Homo sapiens_hsa04978 | 1.00199027 |
| 53 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.99173394 |
| 54 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.99065212 |
| 55 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.97604412 |
| 56 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.94572242 |
| 57 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.94540595 |
| 58 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.93375307 |
| 59 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.92249910 |
| 60 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.89796274 |
| 61 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.88555422 |
| 62 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.88486397 |
| 63 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.87654759 |
| 64 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.84599914 |
| 65 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.83006981 |
| 66 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.82608655 |
| 67 | Melanogenesis_Homo sapiens_hsa04916 | 0.81433629 |
| 68 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.79977941 |
| 69 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.77317200 |
| 70 | Alzheimers disease_Homo sapiens_hsa05010 | 0.76312005 |
| 71 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.75921528 |
| 72 | Bile secretion_Homo sapiens_hsa04976 | 0.74595416 |
| 73 | Glioma_Homo sapiens_hsa05214 | 0.73891001 |
| 74 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.72902905 |
| 75 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.72791124 |
| 76 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.71936830 |
| 77 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.70522036 |
| 78 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.70046530 |
| 79 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.69870532 |
| 80 | Focal adhesion_Homo sapiens_hsa04510 | 0.69347419 |
| 81 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.68414759 |
| 82 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.67792214 |
| 83 | Pertussis_Homo sapiens_hsa05133 | 0.65954662 |
| 84 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.65864742 |
| 85 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.64245576 |
| 86 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.63252008 |
| 87 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.62662782 |
| 88 | Circadian rhythm_Homo sapiens_hsa04710 | 0.61806562 |
| 89 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.60660010 |
| 90 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.59897130 |
| 91 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.59386140 |
| 92 | Tight junction_Homo sapiens_hsa04530 | 0.58309741 |
| 93 | Parkinsons disease_Homo sapiens_hsa05012 | 0.57539005 |
| 94 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.57537527 |
| 95 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.57333219 |
| 96 | Adherens junction_Homo sapiens_hsa04520 | 0.56291253 |
| 97 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.55830881 |
| 98 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.55467133 |
| 99 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.55393722 |
| 100 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.54438810 |
| 101 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.54060538 |
| 102 | Alcoholism_Homo sapiens_hsa05034 | 0.50624080 |
| 103 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.50571939 |
| 104 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.49536347 |
| 105 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.48735353 |
| 106 | Amoebiasis_Homo sapiens_hsa05146 | 0.47459356 |
| 107 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.46384040 |
| 108 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.45816892 |
| 109 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.44142117 |
| 110 | Asthma_Homo sapiens_hsa05310 | 0.42255904 |
| 111 | ABC transporters_Homo sapiens_hsa02010 | 0.41299550 |
| 112 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.40997170 |
| 113 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.40839011 |
| 114 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.39715948 |
| 115 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.39000303 |
| 116 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.38991395 |
| 117 | Endocytosis_Homo sapiens_hsa04144 | 0.38910418 |
| 118 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.38120396 |
| 119 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.37264204 |
| 120 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.37200721 |
| 121 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.35502857 |
| 122 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.35446870 |
| 123 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.35339879 |
| 124 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.33853944 |
| 125 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.33549457 |
| 126 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.33487997 |
| 127 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.33431372 |
| 128 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.33144512 |
| 129 | Huntingtons disease_Homo sapiens_hsa05016 | 0.31409808 |
| 130 | Prion diseases_Homo sapiens_hsa05020 | 0.30785853 |
| 131 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.29485017 |
| 132 | Endometrial cancer_Homo sapiens_hsa05213 | 0.28147877 |
| 133 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.27858263 |
| 134 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.27805364 |
| 135 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.27722272 |
| 136 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.25899627 |
| 137 | Phagosome_Homo sapiens_hsa04145 | 0.25311254 |

